Pro-Dex, Inc. (PDEX)
NASDAQ
Key stats Fiscal year 2026
Income statement
- Revenue
- 77,548,000 16.5%
- Net income
- 13,662,000 52.2%
- Gross profit
- 24,335,000
- Operating income
- 12,991,000
- Earnings per share
- 4.24 55.3%
- R&D expense
- 3,345,000
Growth and profitability
- Gross margin
- 31.38
- Operating margin
- 16.75
- Net margin
- 17.62
- Return on equity
- 28.68
- Return on assets
- 18.34
- Free cash flow margin
- 8.72
Balance sheet
- Total assets
- 74,509,000
- Total liabilities
- 26,876,000
- Shareholders' equity
- 47,633,000
- Cash and equivalents
- 8,192,000
- Debt
- 17,513,000
- Net debt
- 9,321,000
- Current ratio
- 4.10
- Debt to equity
- 0.37
Cash flow and ratios
- Operating cash flow
- 7,242,000
- Free cash flow
- 6,759,000
Shareholder returns
- Share buybacks
- 3,408,000
- Shares outstanding
- 3,200,001
- Book value per share
- 14.89
Company information
- Headquarters
- Irvine, CA
- Exchange
- NASDAQ
- Fiscal year end
- 06-30
- Industry (SEC)
- Surgical & Medical Instruments & Apparatus
Fiscal year end: · Source: SEC EDGAR
Pro-Dex, Inc. trades on NASDAQ under the ticker symbol PDEX. This page brings together its price chart, company profile, key financial figures and technical indicators.